Méndez R, Feced L, Alcaraz-Serrano V, González-Jiménez P, Bouzas L, Alonso R, Martínez-Dolz L, Hervás D, Fernández-Barat L, Torres A et al (2022) Cardiovascular events during and after bronchiectasis exacerbations and long-term mortality. Chest 161(3):629–636

Article  PubMed  Google Scholar 

Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, Dicker A, Wrobel K, Elborn JS, Walker B et al (2017) Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med 195(10):1384–1393

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G et al (2018) Characterization of the “frequent exacerbator phenotype” in bronchiectasis. Am J Respir Crit Care Med 197(11):1410–1420

Article  PubMed  Google Scholar 

Chai YH, Xu JF (2020) How does pseudomonas aeruginosa affect the progression of bronchiectasis? Clin Microbiol Infect 26(3):313–318

Article  CAS  PubMed  Google Scholar 

Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD (2015) A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 12(11):1602–1611

PubMed  Google Scholar 

Pieters A, Bakker M, Hoek RAS, Altenburg J, van Westreenen M, Aerts J, van der Eerden MM (2019) Predicting factors for chronic colonization of pseudomonas aeruginosa in bronchiectasis. Eur J Clin Microbiol Infect Dis: Off Publ European Soc Clin Microbiol 38(12):2299–2304

Article  CAS  Google Scholar 

Wang LL, Lu HW, Li LL, Gao YH, Xu YH, Li HX, Xi YZ, Jiang FS, Ling XF, Wei W et al (2023) Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study. Respir Res 24(1):84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai CC, Lee K, Xiao Y, Ahmad N, Veeraraghavan B, Thamlikitkul V, Tambyah PA, Nelwan RH, Shibl AM, Wu JJ et al (2014) High burden of antimicrobial drug resistance in Asia. J Glob Antimicrob Resist 2(3):141–147

Article  PubMed  Google Scholar 

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S et al: Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 2018, 52(2).

Antimicrobial Resistance C (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629–655

Article  Google Scholar 

Gao YH, Guan WJ, Zhu YN, Chen RC, Zhang GJ (2018) Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications. Int J Chron Obstruct Pulmon Dis 13:237–246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J et al (2023) Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. The Lancet Microbe 4(3):e159–e170

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO. Media Center. WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization: Feb 27, 2017. https://www.who.int/news/item/27-02-2017who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed Jan 02, 2024).

Chang CH, Chang CH, Huang SH, Lee CS, Ko PC, Lin CY, Hsieh MH, Huang YT, Lin HC, Li LF et al (2024) Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis. Ann Clin Microbiol Antimicrob 23(1):15

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS et al: Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. European Respiratory Journal 2017, 49(6).

Wolff BJ, Bramley AM, Thurman KA, Whitney CG, Whitaker B, Self WH, Arnold SR, Trabue C, Wunderink RG, McCullers J et al (2017) Improved detection of respiratory pathogens by use of high-quality sputum with taqman array card technology. J Clin Microbiol 55(1):110–121

Article  PubMed  Google Scholar 

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281

Article  CAS  PubMed  Google Scholar 

Cook MR, O’Connell K, Qiu Q, Riggle AJ, Shoultz TH, Maine RG, Arbabi S, O’Keefe GE, Cuschieri J, Maier RV et al (2018) Duration of respiratory failure after trauma is not associated with increased long-term mortality. Crit Care Med 46(8):1263–1268

Article  PubMed  Google Scholar 

Wang HE, Prince DK, Drennan IR, Grunau B, Carlbom DJ, Johnson N, Hansen M, Elmer J, Christenson J, Kudenchuk P et al (2017) Post-resuscitation arterial oxygen and carbon dioxide and outcomes after out-of-hospital cardiac arrest. Resuscitation 120:113–118

Article  PubMed  PubMed Central  Google Scholar 

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K et al: European Respiratory Society guidelines for the management of adult bronchiectasis. European Respiratory Journal 2017, 50(3).

Vallabhaneni S, Huang JY, Grass JE, Bhatnagar A, Sabour S, Lutgring JD, Campbell D, Karlsson M, Kallen AJ, Nazarian E, Snavely EA (2021) Antimicrobial susceptibility profiles to predict the presence of carbapenemase genes among carbapenem-resistant pseudomonas aeruginosa isolates. J Clin Microbiol 59(6):10–128

Article  Google Scholar 

Conceicao M, Shteinberg M, Goeminne P, Altenburg J, Chalmers JD: Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis. Eur Respir Rev 2024, 33(171).

Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT (2012) Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 186(7):657–665

Article  CAS  PubMed  Google Scholar 

Wang R, Ding S, Lei C, Yang D, Luo H (2021) The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study. Ann Med 53(1):459–469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borekci S, Halis AN, Aygun G, Musellim B (2016) Bacterial colonization and associated factors in patients with bronchiectasis. Annal Thorac Med 11(1):55–59

Article  Google Scholar 

Florin TA, Plint AC, Zorc JJ (2017) Viral bronchiolitis. Lancet 389(10065):211–224

Article  PubMed  Google Scholar 

Tenover FC, Nicolau DP, Gill CM (2022) Carbapenemase-producing pseudomonas aeruginosa—an emerging challenge. Emerg Microb Infect 11(1):811–814

Article  CAS  Google Scholar 

Dhar R, Singh S, Talwar D, Murali Mohan BV, Tripathi SK, Swarnakar R, Trivedi S, Rajagopala S, D’Souza G, Padmanabhan A et al: Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry. Eur Respir J 2023, 61(1).

Araujo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A et al: The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J 2018, 51(2).

Hassoun-Kheir N, Guedes M, Ngo Nsoga MT, Argante L, Arieti F, Gladstone BP, Kingston R, Naylor NR, Pezzani MD, Pouwels KB et al: A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe. Clin Microbiol Infect 2023.